Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Eupraxia Pharmaceuticals Announces Proposed Public Offering
-
Eupraxia Pharmaceuticals (EPRX) PT Raised to $19 at Cantor Fitzgerald
-
Eupraxia's (EPRX) Blockbuster Opportunity Not Fully Priced In - Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Eupraxia Pharmaceuticals (EPRX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Eupraxia Pharmaceuticals (EPRX)
-
Eupraxia Pharmaceuticals closes $80.5 million public offering
-
Eupraxia Pharmaceuticals Announces Closing of US$80.5 Million Public Offering Including Full Exercise of Underwriter Option
-
Eupraxia Pharmaceuticals prices $70 million public offering at $5.50 per share
-
Eupraxia Pharmaceuticals Announces Pricing of US$70 Million Public Offering of Common Shares
-
Eupraxia Pharmaceuticals announces proposed public offering of common shares
-
Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares
